These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32722309)

  • 21. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia Models.
    Abeti R; Baccaro A; Esteras N; Giunti P
    Front Cell Neurosci; 2018; 12():188. PubMed ID: 30065630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
    Hart PE; Lodi R; Rajagopalan B; Bradley JL; Crilley JG; Turner C; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress and altered lipid metabolism in Friedreich ataxia.
    Tamarit J; Obis È; Ros J
    Free Radic Biol Med; 2016 Nov; 100():138-146. PubMed ID: 27296838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions.
    Lynch DR; Farmer G
    Neuronal Signal; 2021 Jun; 5(2):NS20200093. PubMed ID: 34046211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review.
    Jain P; Badgujar L; Spoorendonk J; Buesch K
    Ther Adv Rare Dis; 2022; 3():26330040221139872. PubMed ID: 37180421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy.
    Crombie DE; Pera MF; Delatycki MB; Pébay A
    Int J Cardiol; 2016 Jun; 212():37-43. PubMed ID: 27019046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidants and other pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Pandolfo M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007791. PubMed ID: 19821439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question.
    Armstrong JS; Khdour O; Hecht SM
    FASEB J; 2010 Jul; 24(7):2152-63. PubMed ID: 20219987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease.
    Clark E; Johnson J; Dong YN; Mercado-Ayon E; Warren N; Zhai M; McMillan E; Salovin A; Lin H; Lynch DR
    Neuronal Signal; 2018 Dec; 2(4):NS20180060. PubMed ID: 32714592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a Novel Oleic Acid Analog with Protective Effects in Multiple Cellular Models of Friedreich Ataxia.
    Cotticelli MG; Forestieri R; Xia S; Joyasawal S; Lee T; Xu K; Smith Iii AB; Huryn DM; Wilson RB
    ACS Chem Neurosci; 2020 Sep; 11(17):2535-2542. PubMed ID: 32786299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin in Friedreich ataxia.
    Mariotti C; Nachbauer W; Panzeri M; Poewe W; Taroni F; Boesch S
    J Neurochem; 2013 Aug; 126 Suppl 1():80-7. PubMed ID: 23859343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales.
    Bürk K; Schulz SR; Schulz JB
    J Neurochem; 2013 Aug; 126 Suppl 1():118-24. PubMed ID: 23859347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dynamin-related protein 1 is decreased and the mitochondrial network is altered in Friedreich's ataxia cardiomyopathy.
    Chidipi B; Angulo MB; Shah SI; Rieser M; Ullah G; McDonald TV; Noujaim SF
    Int J Biochem Cell Biol; 2022 Feb; 143():106137. PubMed ID: 34923139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
    Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
    Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparent Opportunities and Hidden Pitfalls: The Conflicting Results of Restoring NRF2-Regulated Redox Metabolism in Friedreich's Ataxia Pre-Clinical Models and Clinical Trials.
    Tiberi J; Segatto M; Fiorenza MT; La Rosa P
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
    Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiogical and therapeutic progress in Friedreich ataxia.
    Puccio H; Anheim M; Tranchant C
    Rev Neurol (Paris); 2014 May; 170(5):355-65. PubMed ID: 24792433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models.
    Sandi C; Sandi M; Jassal H; Ezzatizadeh V; Anjomani-Virmouni S; Al-Mahdawi S; Pook MA
    PLoS One; 2014; 9(2):e89488. PubMed ID: 24586819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidants and other pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Pandolfo M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007791. PubMed ID: 22513953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.